Meanwhile, cell block specimens stained with anti-CD26 pAb purchased from R&D Systems (control pAb) exhibited a clear staining pattern of CD26, (Fig 1A-iii), revealing 19–32 mAb to be inappropriate for the detection of denatured CD26 expression in FFPE clinical tumor samples. This evidence concerns the gene DPP4 and neoplasm.